NRD
CNMD icon

Nebula Research & Development’s CONMED CNMD Stock Holding History

Nebula Research & Development’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,957
Closed -$324K – 776
2023
Q4 		$324K Buy
+2,957
New +$306K 0.1% 408

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Nebula Research & Development's CNMD Position: Q1 2024 in Review

Nebula Research & Development sold out of CONMED (CNMD) in Q1 2024, closing a stake of 2,957 shares — an estimated $324K sold.

Nebula Research & Development first reported a position in CNMD in Q4 2023 and held it in 1 quarter. The position peaked at $324K in Q4 2023. 298 funds tracked by Wall St. Rank hold CNMD as of Q1 2024.

  • Nebula Research & Development reported no remaining CONMED position as of Q1 2024 after selling out during the quarter.
  • Nebula Research & Development sold 2,957 CONMED shares in Q1 2024, an estimated $324K.
  • Nebula Research & Development first reported a position in CONMED in Q4 2023 and held it in 1 quarter.
  • Nebula Research & Development's CONMED position peaked at $324K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held CONMED as of Q1 2024.

Based on Nebula Research & Development's 13F filing for Q1 2024, filed 15 May 2024.